Contact this trialFirst, we need to learn more about you.
Autophagy Inhibitor
Ulixertinib + Hydroxychloroquine for Gastrointestinal Cancer
Recruiting1 awardPhase 1
Salt Lake City, Utah
This trial is testing a new cancer drug, ulixertinib, combined with the existing drug hydroxychloroquine. The trial will start with a small group of patients to see if the ulixertinib is safe and what side effects there are. If it is safe, then more patients will be enrolled.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.